4-acetylantroquinonol-b and Prostatic-Neoplasms

4-acetylantroquinonol-b has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 4-acetylantroquinonol-b and Prostatic-Neoplasms

Article	Year
4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models. International journal of molecular sciences, 2022, Jan-27, Volume: 23, Issue:3 Topics: 4-Butyrolactone; Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cell Survival; Cyclohexanones; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; PC-3 Cells; Phosphatidylinositol 3-Kinase; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2022

Article

Year

4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.

International journal of molecular sciences, 2022, Jan-27, Volume: 23, Issue:3

Topics: 4-Butyrolactone; Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cell Survival; Cyclohexanones; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; PC-3 Cells; Phosphatidylinositol 3-Kinase; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2022